Showing 1 - 3 results of 3 for search 'Zoran Culig', query time: 0.02s Refine Results
  1. 1
    Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report

    Pembrolizumab and olaparib in a cisplatin-refractory testicular cancer patient with a high TMB: first case report by Nils C. H. van Creij, Gerald Klinglmair, Leonhard Gruber, Antonia Partl, Alain G. Zeimet, Frédéric R. Santer, Simon Schnaiter, Roman Mayr, Felizian Lackner, Zoran Culig, Andreas Seeber, Renate Pichler

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer

    The MicroRNA miR-454 and the mediator complex component MED12 are regulators of the androgen receptor pathway in prostate cancer by Juan Guzman, Martin Hart, Katrin Weigelt, Angela Neumann, Achim Aigner, Chiara Andolfi, Florian Handle, Stefanie Rheinheimer, Ulrike Fischer, Uta D. Immel, Verena Lieb, Eckart Meese, Zoran Culig, Bernd Wullich, Helge Taubert, Sven Wach

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    ZEB1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat

    ZEB1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat by Simone Meidhof, Simone Brabletz, Waltraut Lehmann, Bogdan‐Tiberius Preca, Kerstin Mock, Manuel Ruh, Julia Schüler, Maria Berthold, Anika Weber, Ulrike Burk, Michael Lübbert, Martin Puhr, Zoran Culig, Ulrich Wellner, Tobias Keck, Peter Bronsert, Simon Küsters, Ulrich T Hopt, Marc P Stemmler, Thomas Brabletz

    Published 2015-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: